Food and Drug Administration: Orange book: approved drug products with therapeutic equivalence evaluations. 2016. Available at: http://www.accessdata.fda.gov/scripts/cderlob/defaulr.cfm. Accessed October 10, 2016
Food and Drug Administration: Ortho Evra (norelgestrominl ethinyl estradiol) transdermal system. 2015b. Available at: http://www.fda.gov/Safety/Med �latch/SafetyInformation/ucm211821.htm. Accessed July 7,n2016
Fox Me, Oat-Judge J, Severson K, et al: Immediate placement of intrauterine devices after irst and second trimester pregnancy termination. Contraception 83(1):34, 2011
Fulkerson Schaefer 5, Gimovsky Ae, et al: Pregnancy and delivery with an intrauterine device in situ: outcomes in the National Inpatient Sample Database. J Matern Fetal Neonatal Med October 26, 201 [Epub ahead of print]
Furlong A: Ecropic pregnancy risk when contraception fails. J Reprod Med 47:881, 2002
Gallo MF, Grimes DA, Lopez LM, et al: Non-latex versus latex male condoms for contraception. Cochrane Database Syst Rev 1 :CD003550, 2006, Reassessed 2012a
Gallo MF, Grimes DA, Schulz KF: Cervical cap versus diaphragm for contraception. Cochrane Database Syst Rev 4:CD003551, 2002, Reassessed 2012b
Gallo MF, Lopez LM, Grimes DA, et al: Combination contraceptives: efects on weight. Cochrane Database Syst Rev 1:CD003987, 2014
Gardner JM, Mishell DR Jr: Analysis of bleeding patterns and resumption of fertility following discontinuation of a long-acting injectable contraceptive. Fertil Steril 21 :286, 1970
Gemzell-Danielsson K, Rabe T, Cheng L: Emergency contraception. Gynecol Endocrinol 29 Suppl 1: 1, 2013
Gemzell-Danielsson K, Schellschmidt I, Apter 0: A randomized, phase II study describing the eicacy, bleeding proile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena. Fertil Steril 97(3):616, 2012
Godfrey EM, Folger SG, Jeng G, et al: Treatment of bleeding irregularities in women with copper-containing IUDs: a systematic review. Contraception 87(5):549,n2013
Grimes DA, Jones LB, Lopez LM, et al: Oral contraceptives for functional ovarian cysts. Cochrane Database Syst Rev 4:CD006134, 2014
Grimes DA, Schulz KF: Antibiotic prophylaxis for intrauterine contraceptive device insertion. Cochrane Database Syst Rev 2:CD001327, 2001, Reaffirmed 2012
Grunloh OS, Casner T, Secura GM, et al: Characteristics associated with discontinuation of long-acting reversible contraception within the irst 6 months of use. Obstet Gynecol 122(6):1214,n2013